Syed Quibtiya

Evaluation of Surrogate Risk Factors for Severe Progression of COVID-19 in Tobacco Smoking Sub-Population and its Possible Amelioration by Immune Modulators

N. Shah, S. U. Nabi, K. Dar, 2022 .

Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India

N. Shah, S. Taifa, S. U. Nabi, 2023, Healthcare.

Repurposing of Mycobacterium indicus pranii for the severe form of COVID‐19 patients in India: A cohort study

M. Rather, N. Shah, S. U. Nabi, 2021, Journal of medical virology.